Suchergebnisse - "Li, Yue-Yue"

PubPharm (86)

1

High-dose dual therapy versus bismuth-containing quadruple therapy for the eradication of Helicobacter pylori : A systematic review and meta-analysis

enthalten in: Journal of digestive diseases | 2024

von Wang, H. | Kong, Q. | Li, Y. | +2

2

Individualized small bowel preparation for computed tomography enterography : A prospective randomized controlled trial

enthalten in: Journal of gastroenterology and hepatology | 2024

von Sun, Y. | Li, Y. | Zheng, M. | +7

3

Corrigendum to "Cilengitide inhibits osteoclast adhesion through blocking the αvβ3-mediated FAK/Src signaling pathway" [Heliyon 9(7) (July 2023) e17841

enthalten in: Heliyon | 2024

von Guo, D. | Chen, Z. | Fu, Y. | +7

ErratumFor: Heliyon. 2023 Jun 29;9(7):e17841. - PMID 37539209

4

Comparative analysis of large language models in medical counseling : A focus on Helicobacter pylori infection

enthalten in: Helicobacter | 2024

von Kong, Q. | Ju, K. | Wan, M. | +5

5

Efficacy and safety of a 14-day modified concomitant therapy for refractory Helicobacter pylori infection : a pilot study

enthalten in: Journal of gastroenterology and hepatology | 2023

von Zeng, S. | Wang, J. | Liu, J. | +10

6

Fucoidan Ameliorates Ferroptosis in Ischemia-reperfusion-induced Liver Injury through Nrf2/HO-1/GPX4 Activation

enthalten in: Journal of clinical and translational hepatology | 2023

von Li, J. | Dai, W. | Mo, W. | +4

7

Can the optimal treatment duration be determined in bismuth-containing therapies for Helicobacter pylori eradication?

enthalten in: Clinical and experimental medicine | 2023

von Ding, Y. | Li, Y.

CommentOn: Chin Med J (Engl). 2022 Dec 20;135(24):2899-2910. - PMID 36579940

8

Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis

enthalten in: Materials today. Bio | 2023

von Chen, Z. | Du, D. | Fu, Y. | +9

9

The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day : a systematic review and meta-analysis

enthalten in: Clinical and experimental medicine | 2023

von Ding, Y. | Li, Y. | Liu, J. | +12

10

Cilengitide inhibits osteoclast adhesion through blocking the αvβ3-mediated FAK/Src signaling pathway

enthalten in: Heliyon | 2023

von Guo, D. | Chen, Z. | Fu, Y. | +7

ErratumIn: Heliyon. 2023 Nov 24;10(1):e22629. - PMID 38332873

1
2
3
4
5
6
7
8
9
Nächster »
[9]